Jeffrey M. Leiden
2018 - Vertex Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $3,440,151 |
|---|---|
| Option Awards | $4,243,973 |
| Salary | $1,300,000 |
| Stock Awards | $9,800,288 |
| Other | $14,735 |
| Total | $18,799,147 |
Leiden received $9.8M in stock awards, accounting for 52% of the total pay in 2018.
Leiden also received $3.4M in non-equity incentive plan, $4.2M in option awards, $1.3M in salary and $14.7K in other compensation.
Rankings
In 2018, Jeffrey M. Leiden's compensation ranked 192nd out of 14,244 executives tracked by ExecPay. In other words, Leiden earned more than 98.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 192 out of 14,244 | 99th |
Division Manufacturing | 57 out of 5,758 | 99th |
Major group Chemicals And Allied Products | 19 out of 2,119 | 99th |
Industry group Drugs | 17 out of 1,808 | 99th |
Industry Pharmaceutical Preparations | 11 out of 1,382 | 99th |
Pay ratio
| Jeffrey M. Leiden's Pay | $18,799,147 |
|---|---|
| Median Employee's Pay | $232,178 |
| Pay Ratio | 81to 1 |
In 2018, the annual total compensation of Jeffrey M. Leiden was $18,799,147.
The annual total compensation of the median employee at Vertex Pharmaceuticals was $232,178.
The ratio of Jeffrey M. Leiden's pay to the pay of median employee was therefore 81 to one.
Leiden's colleagues
We found six more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2018.
2018
Jeffrey Chodakewitz
Vertex Pharmaceuticals
Chief Medical Officer
2018
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2018
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2018
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2018
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2018
Thomas Graney
Vertex Pharmaceuticals